Episode
Memory Stocks Surge, Early xAI & SpaceX Investor Peter Diamandis, Teva Pharma CEO 4/29/26
- Podcast
- CNBC’s “Money Movers”
- Published
- Apr 29, 2026
- Duration seconds
- 2605
- Processing state
not_requested- Canonical source
- https://www.cnbc.com
Actions
POST https://stenobird.com/v1/public/podcasts/cnbc-s-money-movers-6706747/episodes/memory-stocks-surge-early-xai-spacex-investor-peter-diamandis-teva-pharma-ceo-4-29-26/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/cnbc-s-money-movers-6706747/memory-stocks-surge-early-xai-spacex-investor-peter-diamandis-teva-pharma-ceo-4-29-26.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
What does the surge in memory stocks signal about the broader AI trade? A look at those moves, ahead of four Mag 7 earnings reports tonight. Then early SpaceX and xAI investor Peter Diamandis on Elon Musk’s lawsuit against OpenAI. Plus, how to value a SpaceX IPO. And the CEO of Teva Pharma after reporting an earnings beat and announcing its first acquisition in a decade.